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An overarching
strategic goal of the
ACC is to be the
preeminent source of
cardiovascular
clinical data that can
help physicians and
hospitals deliver
high-quality and
affordable patientOimprove care, and lower healthcare costs has engendered much debate anddiscussion in the healthcare community as well as among consumers, industry,
and state and local lawmakers. At the American College of Cardiology (ACC), we
believe that clinical data registriesdlike those that fall under the umbrella of the
National Cardiovascular Data Registry (NCDR)dare an important part of these
discussions.
In the cardiovascular space, the College is leading a number of efforts to leverage its
7 NCDR programs (6 hospital based and 1 ambulatory) to track and assess quality of
care and outcomes associated with certain populations of patients with cardiovascular
disease in the United States and internationally. In addition, the ACC is using its registry
data to perform cutting-edge health outcomes research and identify gaps in cardiovascular
care.
The ACC has long used registry data to showcase improvements in quality of care. For
example, the ACC’s CathPCI Registry data have been used to provide a contemporary
view of the current practice of invasive cardiology in the United States, including infor-
mation related to the availability of on-site cardiac surgery, appropriate use of percutaneous
coronary interventions (PCIs), patient characteristics, and door-to-balloon (D2B) times
for primary PCI. Data have played key roles in helping reduce D2B times, controlling
costs associated with preventable procedural complications, limiting hospital readmissions,
and more.
Last year’s NCDR report, published in JACC, highlighted several success stories between
2008 and 2011. Data from both the CathPCI Registry and the ACTION Registry-GWTG
found increased adherence to guideline-recommended D2B times of 90 min, as well as
consistent prescription of recommended drug therapies such as aspirin, beta-blockers, and
lipid-lowering agents (1).
Based on ACTION Registry-GWTG data, the percentage of ST-segment elevation
myocardial infarction patients (both nontransfer and transfer) receiving reperfusion within
the guideline-recommended time frame increased signiﬁcantly between 2008 and 2011.
The percentage of D2B times <90 min for nontransfer patients increased from 81% in 2008
to 94.2% in 2011, and the percentage of D2B times <90 min for transfer patients increased
from 18% in 2008 to 30.4% in 2011 (1).
CathPCI data also showed that prescription of aspirin and P2Y12 receptor antagonist
at discharge remained relatively steady between 96% and 98% from 2009 to 2011. Pre-
scription of lipid lowering agents rose from 89.7% in 2009 to 92.5% in 2011, whereas
beta-blocker prescriptions increased from 83.1% to 86.3% over the same period. Consistency
in practice patterns is 1 marker of success (1).
Registry data play an important role in pinpointing areas where the profession can
continue to improve. For example, the NCDR report showed opportunities to improve
care.
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undergoing elective PCI, but also to clarify areas of
uncertainty. According to the report, and using the
deﬁnitions of appropriateness in place at time of publi-
cation, a little more than one-half (52.8%) of patients
without an ACS indication in 2011 received PCI that
was deﬁned as appropriate, 37.3% fell into the category
of uncertain appropriateness, and approximately 10%
were deemed inappropriate. Follow-up of patients un-
dergoing carotid artery stenting or carotid endarterec-
tomy is another area where data indicate room for
improvement. According to CARE Registry data,
follow-up performed within 30 days following a proce-
dure was 60% among carotid artery stenting patients
and only 38.7% among carotid endarterectomy patients
in 2011 (1).
On the ambulatory front, data from the PINNACLE
Registry indicate gaps in the use of anticoagulants for stroke
prevention in patients with atrial ﬁbrillation (AF), as well as
in the area of hypertension management. Only 57.2% of
patients with AF in PINNACLE in 2011 were prescribed
guideline-recommended anticoagulation therapy, clearly
underscoring a need for increased education for patients
and clinicians. Meanwhile, approximately 95% of providers
regularly recorded patient blood pressures, but only 34.5%
of patients had explicitly documented plans of care for
hypertension (1).
Taking things a step further, registry data are
proving to be useful beyond just identifying trends and
gaps in care. They are increasingly used for research,
performance improvement, and lifelong learning
activities. Data have also been used to develop per-
formance measures such as the National Quality
Forum–endorsed 30-day PCI mortality measure and
other risk-adjusted metrics for PCI, including bleeding
and acute kidney injury. To date, data from the reg-
istry have been used in more than 200 studies pub-
lished in medical, peer-reviewed journals, including
JACC, and over 60 are currently in the research and
publication process.
Physician-level dashboards, like those associated
with the CathPCI Registry, support quality improve-
ment, volume tracking, and maintenance of certiﬁcation
activities, as well as overall outcomes reports that
have evolved over time to incorporate appropriate use
criteria–based metrics. As a result of this integration,
hospitals can track the appropriateness of PCIs per-
formed and benchmark their information with other
hospitals in the United States. Additionally, hospitalsare able to identify opportunities to improve the selec-
tion of patients who undergo PCI by using the “insti-
tutional rates of procedural appropriateness” data
included in the report.
Recent quality initiatives are also taking advantage
of NCDR data. The ACC’s Anticoagulation Initiative
was developed in response to the gaps in anticoagulation
care identiﬁed by the PINNACLE Registry, whereas
the new Surviving MI Initiative is leveraging the
broad registry community to improve survival after
myocardial infarction. Reducing Radiation Risk, another
new quality initiative, not only aims to improve pa-
tient outcomes, but has been approved by the American
Board of Pediatrics for Maintenance of Certiﬁcation
Part IV credit. The program is focused on reducing
radiation exposure for IMPACT Registry patients un-
dergoing cardiac catheterization procedures for congen-
ital heart disease.
Clinical trial recruitment is one of the most exciting
new developments for data registries. In an effort to
help address the need for strong clinical trial partici-
pation, reduce the burden for both practices and pa-
tients, and potentially drive down costs associated with
recruitment, the PINNACLE Registry Research Alli-
ance provides opportunities to facilitate patient identi-
ﬁcation, screening, and recruitment. After patients are
identiﬁed through the PINNACLE Registry, their
personal physician can facilitate a constructive shared
decision-making encounter around possible trial
participation.
In addition to trial recruitment, research participation
can help patients access therapies that are not easily
available outside of cardiovascular trials, provide partic-
ipants with cutting-edge research results to improve
practice and patient care, and provide access to clinical
data and superior informatics for cutting-edge research
opportunities.
The College has also been working with various state
departments of health, insurance payers, and industry
partners to promote quality of care and is currently
working on policies with legislators that include the
recommendation of participation in registries to improve
patient outcomes. Internationally, the ACC is working
with the International Consortium of Cardiovascular
Registries to enhance the way device registries are used
across the practice of cardiology and around the world.
Opportunities abound to create a collaborative global
network to inform quality of care measurement and
feedback, device surveillance, pre- and post-market
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comes, and more.
An overarching strategic goal of the ACC is to be the
preeminent source of cardiovascular clinical data that
can help physicians and hospitals deliver high-quality
and affordable patient care. The challenge lies in
continuing to engage physicians, nurses, administrators,
hospitals, and other stakeholders in the registry pro-
grams in a manner that ensures the highest level of data
quality, broader use and interpretation of data reports,
and ongoing commitments to improving the delivery of
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